EP13.05. Temozolomide-associated Hypermutation and Response to Immunotherapy in Advanced Pulmonary Neuroendocrine Tumors. - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Wieneke Buikhuisen
Meta Tag
Speaker Wieneke Buikhuisen
Topic SCLC & Neuroendocrine Tumors: NETs
WCLC 2023 conference
immunotherapy response
advanced pulmonary neuroendocrine tumors
temozolomide treatment
well differentiated PNET
DNA mismatch repair pathway
O6-methylguanine DNA methyltransferase
TEM-associated hypermutation
tumor mutational burden
checkpoint inhibitors
Powered By